NIH:
- STrengthening Research Opportunities for NIH Grants (STRONG): Structured Institutional Needs Assessment and Action Plan Development for Resource Limited Institutions (RLIs) (UC2 – Clinical Trial Not Allowed) (PAR-23-144) National Institute on Minority Health and Health Disparities National Center for Advancing Translational Sciences National Heart, Lung, and Blood Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute of Nursing Research Office of Disease Prevention Office of Research on Women’s Health Application Receipt Date(s): September 18, 2025
- Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed) (PAR-23-149) National Institute of Mental Health Application Receipt Date(s): March 12, 2026
- Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) (PAR-23-156) National Institutes of Health National Center for Complementary and Integrative Health National Cancer Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Deafness and Other Communication Disorders National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Library of Medicine Application Receipt Date(s): Multiple dates, see announcement.
- Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) (PAR-23-161) National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Neurological Disorders and Stroke Application Receipt Date(s): May 22, 2023
- Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) (PAR-23-168) National Institute of Mental Health Application Receipt Date(s): May 07, 2026
- Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) (PAR-23-169) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): August 01, 2025
- Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed) (PAR-23-267) National Center for Advancing Translational Sciences Application Receipt Date(s): Multiple dates, see announcement.
- Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed (PAR-23-268) National Center for Advancing Translational Sciences Application Receipt Date(s): June 06, 2025
- Synthetic Nucleic Acid Platforms for HIV-1 (SNAPH): (R61/R33 Clinical Trial Not Allowed) (RFA-AI-23-026) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): August 02, 2023
- Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed) (RFA-CA-23-029) National Cancer Institute Application Receipt Date(s): July 03, 2024
- SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) (RFA-CA-23-034) National Cancer Institute Application Receipt Date(s): Not Applicable
- Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) (RFA-CA-23-035) National Cancer Institute National Human Genome Research Institute National Institute of Biomedical Imaging and Bioengineering National Institute on Drug Abuse Application Receipt Date(s): August 21, 2023
- Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) (RFA-CA-24-005) National Cancer Institute Application Receipt Date(s): October 13, 2023
- Ending the HIV Epidemic: Focus on Justice Populations with SUD (R61/R33 Clinical Trial Required) (RFA-DA-24-015) National Institute on Drug Abuse Application Receipt Date(s): August 16, 2023
- Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed) (RFA-DA-24-020) National Institute on Drug Abuse Application Receipt Date(s): November 13, 2023
- Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required) (RFA-DA-24-021) National Institute on Drug Abuse Application Receipt Date(s): November 13, 2023
- Ending the HIV Epidemic: Resource Center to Engage Justice-Involved Populations (U24 Clinical Trial Optional) (RFA-DA-24-022) National Institute on Drug Abuse Application Receipt Date(s): August 16, 2023
- Ending the HIV Epidemic: Focus on Justice Populations with SUD-Data Coordination and Dissemination Center (UM1 Clinical Trial Optional) (RFA-DA-24-023) National Institute on Drug Abuse Application Receipt Date(s): August 16, 2023
- Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional) (RFA-DA-24-038) National Institute on Drug Abuse Application Receipt Date(s): February 14, 2025
- Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional) (RFA-ES-23-001) National Institute of Environmental Health Sciences Application Receipt Date(s): October 02, 2023
- Renewal-Native American Tribes Outreach, Education, and Training to Enhance Food Safety and FSMA Compliance (U01) Clinical Trial Not Allowed (RFA-FD-23-032) Food and Drug Administration Application Receipt Date(s): June 20, 2023
- Data Integration and Statistical Analysis Methods (DISAM) (U01 Clinical Trial Not Allowed) (RFA-HG-23-005) National Human Genome Research Institute Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Mental Health Application Receipt Date(s): November 20, 2023
- BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) (RFA-NS-23-026) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health Office of Behavioral and Social Sciences Research Application Receipt Date(s): Multiple dates, see announcement.
- Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) (RFA-TR-23-011) National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Neurological Disorders and Stroke Application Receipt Date(s): May 22, 2023